Dysregulated Expression of FOXM1 Isoforms Drives Progression of Pancreatic CancerXIANGYU KONG; LEI LI; ZHAOSHEN LI et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 13, pp 3987-3996, issn 0008-5472, 10 p.Article

A Novel KLF4/LDHA Signaling Pathway Regulates Aerobic Glycolysis in and Progression of Pancreatic CancerMIN SHI; JIUJIE CUI; JIAWEI DU et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4370-4380, issn 1078-0432, 11 p.Article

FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA ExpressionJIUJIE CUI; MIN SHI; DACHENG XIE et al.Clinical cancer research (Print). 2014, Vol 20, Num 10, pp 2595-2606, issn 1078-0432, 12 p.Article

Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin AZHILIANG JIA; JUN ZHANG; DAOYAN WEI et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4878-4885, issn 0008-5472, 8 p.Article

Loss of krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progressionKANAI, Masashi; DAOYAN WEI; QIANG LI et al.Clinical cancer research. 2006, Vol 12, Num 21, pp 6395-6402, issn 1078-0432, 8 p.Article

The Critical Role of Dysregulated FOXM1―PLAUR Signaling in Human Colon Cancer Progression and MetastasisDAWEI LI; PING WEI; ZHIHAI PENG et al.Clinical cancer research (Print). 2013, Vol 19, Num 1, pp 62-72, issn 1078-0432, 11 p.Article

Targeted inhibition of Spl-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse modelsLIWEI WANG; XIAOHONG GUAN; JUN ZHANG et al.International journal of oncology. 2008, Vol 33, Num 1, pp 161-167, issn 1019-6439, 7 p.Article

Therapeutic Inhibition of Sp1 Expression in Growing Tumors by Mithramycin A Correlates Directly With Potent Antiangiogenic Effects on Human Pancreatic CancerPING YUAN; LIWEI WANG; DAOYAN WEI et al.Cancer. 2007, Vol 110, Num 12, pp 2682-2690, issn 0008-543X, 9 p.Article

Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and AngiogenesisYONG GAO; ZHILIANG JIA; KEPING XIE et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 15, pp 5182-5193, issn 0008-5472, 12 p.Article

Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor ActivityZHILIANG JIA; YONG GAO; KEPING XIE et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 3, pp 1111-1119, issn 0008-5472, 9 p.Article

Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumorsJUN ZHANG; ZHILIANG JIA; QIANG LI et al.Cancer. 2007, Vol 109, Num 8, pp 1478-1486, issn 0008-543X, 9 p.Article